Herbal medicinal product: Rosmarini foliumArray, F: Assessment finalised
Submitted by Anonymous (not verified) on 26 September 2024 - 15:10
Herbal medicinal product: Rosmarini foliumArray, F: Assessment finalised
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation: 05/08/1998, Revision: 27, Status: Authorised
Submitted by Anonymous (not verified) on 26 September 2024 - 13:24
Human medicines European public assessment report (EPAR): Optruma, raloxifene, Date of authorisation: 05/08/1998, Revision: 27, Status: Authorised
New fee regulation: webinar for veterinary industry stakeholders, Online, 24 October 2024
Submitted by Anonymous (not verified) on 26 September 2024 - 13:02
New fee regulation: webinar for veterinary industry stakeholders, Online, 24 October 2024
MedDRA important medical event terms list - version 27.1
Submitted by Anonymous (not verified) on 26 September 2024 - 11:02
MedDRA important medical event terms list - version 27.1
Agenda - ACT EU multi-stakeholder platform annual meeting
Submitted by Anonymous (not verified) on 26 September 2024 - 10:17
Agenda - ACT EU multi-stakeholder platform annual meeting
Agenda of the Extraordinary CHMP meeting 26 September 2024
Submitted by Anonymous (not verified) on 26 September 2024 - 9:00
Agenda of the Extraordinary CHMP meeting 26 September 2024
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 10:00 (CEST) to 26 September 2024, 13:00 (CEST)
Submitted by Anonymous (not verified) on 26 September 2024 - 9:00
Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 26 September 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 26 September 2024, 10:00 (CEST) to 26 September 2024, 13:00 (CEST)
Superseded community herbal monograph on Rosmarinus officinalis L., folium
Submitted by Anonymous (not verified) on 26 September 2024 - 0:00
Superseded community herbal monograph on Rosmarinus officinalis L., folium
List of centrally authorised products with safety-related changes to the product information
Submitted by Anonymous (not verified) on 25 September 2024 - 16:30
List of centrally authorised products with safety-related changes to the product information
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 6, Status: Authorised
Submitted by Anonymous (not verified) on 25 September 2024 - 16:18
Human medicines European public assessment report (EPAR): Giapreza, angiotensin II, Date of authorisation: 23/08/2019, Revision: 6, Status: Authorised